By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



111 West Lemon Avenue

Monrovia  California  91016  U.S.A.
Phone: 626-305-5900 Fax: 626-305-0350



Drug Discovery

Company News
MorphoSys AG And Xencor Publish Final Results From Phase 1/2a Trial Of MOR208 (Xmab5574) In CLL/SLL At Xencor Annual Meeting 12/8/2014 7:40:19 AM
Xencor To Present At The 25th Annual Oppenheimer Healthcare Conference 12/5/2014 12:56:57 PM
Xencor To Present At The 2014 Deutsche Bank (DB) BioFEST Conference 11/25/2014 11:59:09 AM
Xencor Reports Third Quarter 2014 Financial Results 11/11/2014 7:40:47 AM
Xencor Provides Data Updates On XmAb Bispecific Antibody Programs And Announces Presentations At Upcoming American Society of Hematology 2014 Annual Meeting 11/6/2014 9:13:54 AM
Xencor To Present At The 2014 Credit Suisse Annual Healthcare Conference 11/4/2014 9:02:58 AM
Xencor To Host Third Quarter 2014 Financial Results Webcast And Conference Call 11/3/2014 7:37:26 AM
Xencor Regains All Rights From Amgen (AMGN) To Rare AutoImmune Disease Drug, Dumps Arthritis Hopes 10/29/2014 6:16:06 AM
Xencor Appoints Debra Zack, M.D., Ph.D., Vice President, Clinical Development And Lloyd Rowland, Senior Vice President, Chief Compliance Officer and General Counsel 9/3/2014 11:25:37 AM
Xencor To Present At Wedbush Securities 2014 Life Sciences Management Access Conference 8/5/2014 8:03:22 AM